Sec Form 4 Filing - Aisiku Imoigele @ VSEE HEALTH, INC. - 2026-03-23

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Aisiku Imoigele 2. Issuer Name and Ticker or Trading Symbol VSEE HEALTH, INC. [ VSEE] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Co-Chief Executive Officer (Last) (First) (Middle) C/O VSEE HEALTH, INC., 980 N FEDERAL HWY #304 3. Date of Earliest Transaction (MM/DD/YY) 03/23/2026 (Street) BOCA RATON, FL33432 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock, par value $0.0001 per share 03/23/2026 A 128,342 A $ 0.37 ( 1 ) 3,545,031 D Common Stock, par value $0.0001 per share 03/23/2026 A 78,689 A $ 0.61 ( 2 ) 3,416,689 D Common Stock, par value $0.0001 per share 03/23/2026 A 41,379 A $ 1.16 ( 3 ) 3,338,000 D Common Stock, par value $0.0001 per share 03/23/2026 A 40,000 A $ 1.2 ( 4 ) 3,296,621 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Aisiku Imoigele C/O VSEE HEALTH, INC. 980 N FEDERAL HWY #304 BOCA RATON, FL33432 X Co-Chief Executive Officer Signatures /s/ Imoigele Aisiku 03/24/2026 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Reflects shares of common stock issued to the reporting person under the issuer's 2024 Incentive Plan (the "Incentive Plan") as the quarterly equity award owed by the issuer to the reporting person for the quarter ended December 31, 2025 pursuant to the Executive Employment Agreement between the reporting person and the issuer dated December 10, 2025 (the "Employment Agreement"). The number of shares issued to the reporting person is based on the closing price of the common stock on December 31, 2025. ( 2 )Reflects shares of common stock issued to the reporting person under the Incentive Plan as the quarterly equity award owed by the issuer to the reporting person for the quarter ended September 30, 2025 pursuant to the Employment Agreement. The number of shares issued to the reporting person is based on the closing price of the common stock on September 30, 2025. ( 3 )Reflects shares of common stock issued to the reporting person under the Incentive Plan as the quarterly equity award owed by the issuer to the reporting person for the quarter ended June 30, 2025 pursuant to the Employment Agreement. The number of shares issued to the reporting person is based on the closing price of the common stock on June 30, 2025. ( 4 )Reflects shares of common stock issued to the reporting person under the Incentive Plan as the quarterly equity award owed by the issuer to the reporting person for the quarter ended March 31, 2025 pursuant to the Employment Agreement. The number of shares issued to the reporting person is based on the closing price of the common stock on March 31, 2025.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.